Merck to Continue Mesothelioma Clinical Trials Testing Vorinostat – Asbestos.Net News
Filed in Mesothelioma News on Feb.26, 2010
|
Merck to Continue Mesothelioma Clinical Trials Testing Vorinostat
Asbestos.Net News The trial, known as VANTAGE-14, has enrolled more than half of the necessary patients, and is currently recruiting mesothelioma patients who are being … |
::: Merck to Continue Mesothelioma Clinical Trials Testing Vorinostat – Asbestos.Net News

Leave a Reply
You must be logged in to post a comment.